Occam's deep tech practice grows with the placement of Alastair Leighton, PhD as Chemify's Chief Operating Officer (COO). Founded by Lee Cronin, Chemify is a deep tech chemical science innovator that combines chemistry, robotics, and AI to digitally design, discover, and make novel molecules for medicines and advanced materials.
Alastair joins Chemify from MeiraGTx, a gene therapy biotech, where he played a crucial role in transforming the company into a clinical and commercial stage organization. He has previously held leadership positions at GSK, Crucell, and Novartis. With 25 years of experience building and scaling end-to-end manufacturing capabilities within the biopharmaceutical industry across various modalities, he is exceptionally qualified to lead Chemify's ambitious goal of digitizing chemistry.
Alastair holds a BSc in Physics from the University of Sheffield and a PhD in Electrical Engineering from the University of Manchester.
Occam Global is a biotech executive search, recruiting, and leadership advisory firm with specialties across technological fields, including Biotech, TechBio, AI-ML, Cell/Gene Therapy, Diagnostics/Genomics, Medical Devices, Research Tools, Digital Health, Alternative Energy, AgTech, EdTech, Robotics as well as adjacencies within Venture Capital and Private Equity. Occam helps build biotech executive leadership teams that meet the demands of the rapidly developing, competitive, and challenging industries it serves. Occam Global recruits leading C-Suite executives and board members for the most exciting and innovative clients across the world with a specific focus on the UK, Continental Europe, the US, and Asia.